Please login to the form below

Not currently logged in
Email:
Password:

isotretinoin

This page shows the latest isotretinoin news and features for those working in and with pharma, biotech and healthcare.

Recordati snaps up Swiss pharma company Pro Farma

Recordati snaps up Swiss pharma company Pro Farma

The firm sealed a deal with independent family-owned Swiss firm Pro Farma last week that was valued at CHF16m and will add to its portfolio the acne treatment Tretinac (isotretinoin)

Latest news

  • Therapy focus: acne

    Severe Acne drug. Now, there is a whole host of drugs, including the contraceptive pill and many herbal remedies, but one that has courted particular attention is isotretinoin (Roaccutane and Accutane), ... Treatment with this drug has had a high success

  • Alliance Pharma's profit up 17 per cent

    The products include acne treatment Rizuderm (isotretinoin). The move follows previous acquisitions for Alliance this year, including the pain relief therapy Anbesol (benzocaine).

  • Roche drug slapped with caveats

    The Food and Drug Administration (FDA) said it had approved a strengthened distribution programme for Accutane, also known under its generic name isotretinoin, requiring doctors and patients to register and accept

  • News in brief, April 04, 2007

    The FDA is launching a special webpage to warn consumers about the dangers of buying Accutane (isotretinoin) online.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    The product contains isotretinoin (Roaccutane) and has Orphan Drug Designation in the US. ... 50. Patagonia/ Almirall. PAT-001 (isotretinoin-based treatment) – congenital ichthyosis. Licence. 28.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics